Abstract
Hepatitis B Virus (HBV) is a causative agent of both acute and chronic hepatitis, a major etiologic factor of primary hepatocellular carcinoma, and a serious global health problem, with over 240 million estimated chronically infected individuals. Although there are several promising antiviral agents currently in clinical trials, alpha interferon remains the only licensed drug for the treatment of chronic HBV infection. Several cell lines and cell culture assays have been developed to identify potential therapeutics against chronic HBV infection. One of these cell lines, 2.2.15 (1), has been developed into a standardized assay, by the authors’ laboratory, that has been repeatedly shown to be an accurate model of chronic cellular HBV replication and a predictive model of antiviral response for chronic hepadnaviral infection in vivo (2–5). This assay system, described here, is currently that used by the National Institutes of Health-National Institute of Allergy and Infectious Diseases (NIH-NIAID) (contract NO1-AI-45195) as an in vitro screen for antiviral agents against HBV replication.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sells, M. A., Zelent, A. Z., Shvartsman, M., and Acs, G. (1988) Replication intermediates of hepatitis B virus in HepG2 cells that produce infectious virions. J. Virol. 62, 2836–2844.
Korba, B. E. and Gerin, J. L. (1992) Use of a standardized cell culture assay to assess activities of nucleoside analogs against hepatitis B virus replication. Antiviral Res. 19, 55–70.
Korba, B. E. and Gerin, J. L. (1995) Antisense oligonucleotides are effective inhibitors of hepatitis B virus replication in vitro. Antiviral Res. 28, 225–242.
Korba, B. E. (1996) In vitro evaluation of combination therapies against hepatitis B virus replication. Antiviral Res. 29, 49–52.
Korba, B. E. and Boyd, M. R. (1996) Penciclovir is a selective inhibitor of hepatitis B virus replication in cultured human hepatoblastoma cells. Antimicrob. Agents Chemother. 40, 1282–1284.
Acs, G., Sells, M. A., Purcell, R. H., Price, P., Engle, R., Shapiro, M., and Popper, H. (1987) Hepatitis B virus produced by transgected Hep G2 cells causes hepatitis in chimpanzees. Proc. Natl. Acad. Sci. USA 84, 4641–4644.
Moriarty, A. M., Hoyer, B. H., Shih, J. W.-K., Gerin, J. L., and Hamer, D. H. (1981) Expression of the hepatitis B virus surface antigen gene in cell culture by using a simian virus 40 vector. Proc. Natl. Acad. Sci. USA 78, 2606–2610.
Korba, B. E. and Milman, G. (1991) A cell culture assay for compounds which inhibit hepatitis B virus replication. Antiviral Res. 15, 217–228.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Humana Press Inc.
About this protocol
Cite this protocol
Schmidt, K., Korba, B. (2000). Hepatitis B Virus Cell Culture Assays for Antiviral Activity. In: Kinchington, D., Schinazi, R.F. (eds) Antiviral Methods and Protocols. Methods in Molecular Medicine™, vol 24. Humana Press. https://doi.org/10.1385/1-59259-245-7:51
Download citation
DOI: https://doi.org/10.1385/1-59259-245-7:51
Publisher Name: Humana Press
Print ISBN: 978-0-89603-561-4
Online ISBN: 978-1-59259-245-6
eBook Packages: Springer Protocols